Kinnate Biopharma shares owned by Vanguard Group
Quarter-by-quarter ownership of Kinnate Biopharma (KNTE) shares owned by Vanguard Group
from 13F filings
Historical chart of Vanguard Group investment in Kinnate Biopharma
Tip: Access up to 7 years of quarterly data
All positions including Kinnate Biopharma held by Vanguard Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Kinnate Biopharma by Vanguard Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $2.5M | 1.0M | 2.37 |
| 2023-09-30 | $1.4M | 994k | 1.40 |
| 2023-06-30 | $3.0M | 994k | 3.03 |
| 2023-03-31 | $6.4M | 1.0M | 6.25 |
| 2022-12-31 | $6.2M | 1.0M | 6.10 |
| 2022-06-30 | $13M | 996k | 12.61 |
| 2022-03-31 | $16M | 1.5M | 11.26 |
| 2021-09-30 | $43M | 1.9M | 23.02 |
| 2021-06-30 | $28M | 1.2M | 23.30 |
| 2021-03-31 | $41M | 1.3M | 31.16 |
| 2020-12-31 | $33M | 852k | 38.99 |